Aurora Cannabis (TSX:ACB) Stock: Down 34%

Cannabis stocks like Aurora Cannabis are famously volatile, but quarterly results show that the road to profitability is long.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock has plummeted 34% in just the last 10 days. This is a dramatic fall, but it followed a period of strength. And today, Aurora Cannabis stock is still 40% higher year to date.

So, what should we make of this? Why is Aurora Cannabis stock down 34% from its 2021 highs? And what does this mean for investors?

Aurora Cannabis stock: Volatility is just more of the same

Cannabis stocks are not the stocks to buy if volatility makes you nervous. They’re the stocks to buy only under certain circumstances. For example, buy them if you’re bullish on the long-term outlook of the cannabis sector. Also, buy them if you can handle extreme volatility. And lastly, buy them if you can afford to own a basket of cannabis stocks.

Aurora Cannabis stock chart

Aurora Cannabis’s stock price has certainly been the picture of volatility. For a company that’s in a new industry, this should come as no surprise. There are so many unknowns. And for a company that’s in a potentially very lucrative industry, this should also be no surprise. It’s very easy for investors to get excited about the cannabis industry. The potential for cannabis as a medical therapy is huge. The potential for cannabis as a recreational vice, like alcohol, is also huge.

So, how can investors make sense of all of this volatility? Well, we don’t have to. Many successful investors know this. Focusing on the long term is the best strategy. Short-term events are often just noise. They distract us from the big picture. It’s not that we shouldn’t know what’s going on. It’s just that we must be able to distance ourselves from distractions. In the case of Aurora Cannabis stock, profitability is still lacking. There’s still much uncertainty. That’s why I think owning a basket of cannabis stocks diversifies your company-specific risk. Yet it enables you to benefit from the cannabis industry boom.

Aurora Cannabis: Quarterly results disappoint

The potential is well known, I think. The cannabis market is huge. It’s a global market. And it’s a lucrative market that has existed forever — except it has been a black market. So, moving forward with legalization is bringing this market to all. Hopes are high for cannabis companies and cannabis stocks.

But the road to profitability is fraught with obstacles. We have seen this in the few years since legalization. Aurora Cannabis’s second-quarter fiscal 2021 results were a disappointment in general. Revenue came in below analyst expectations. Cash burn remains high. And the 11% year-over-year revenue-growth rate is nothing to write home about.

So, the key factor I would take note of here is expectations. Investor expectations for cannabis companies were always high. And cannabis stocks have gone from being shunned to embraced to shunned and then embraced once again. Aurora Cannabis posted an adjusted EBITDA loss of $12 million in the quarter. Importantly, management has refused to give a timeline for when the company will be EBITDA break even. This certainly doesn’t sit well with investors.

Motley Fool: The bottom line

In closing, Aurora Cannabis stock is reacting to its less-than-impressive quarterly results. The road to profitability will be long. This understandably makes investors nervous. Cannabis stocks are a volatile bunch. Stick with a basket of leading cannabis stocks. Include Aurora Cannabis in your basket, and you will ride the cannabis wave higher.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »